APA (7th ed.) Citation

G, A., L, C., P, O., A, F., A, C., A, F., . . . G, B. (2014). Pharmacogenetic interaction analysis of VEGFR-2 and IL-8 polymorphisms in advanced breast cancer patients treated with paclitaxel and bevacizumab. Pharmacogenomics, 15(16), 1985. https://doi.org/10.2217/pgs.14.140

Chicago Style (17th ed.) Citation

G, Allegrini, et al. "Pharmacogenetic Interaction Analysis of VEGFR-2 and IL-8 Polymorphisms in Advanced Breast Cancer Patients Treated with Paclitaxel and Bevacizumab." Pharmacogenomics 15, no. 16 (2014): 1985. https://doi.org/10.2217/pgs.14.140.

MLA (9th ed.) Citation

G, Allegrini, et al. "Pharmacogenetic Interaction Analysis of VEGFR-2 and IL-8 Polymorphisms in Advanced Breast Cancer Patients Treated with Paclitaxel and Bevacizumab." Pharmacogenomics, vol. 15, no. 16, 2014, p. 1985, https://doi.org/10.2217/pgs.14.140.